|
| Exchange Disseminated Time | Neuland Laboratories Ltd has informed BSE that pursuant to receipt of approval of Foreign Investment Promotion Board ("FIPB"), the Board of Directors of the Company had, on December 17, 2014, allotted 2,804 fully paid up equity shares of a face value of Rs. 10/- each, out of the Rights Issue of 12,25,276 Equity Shares. The allotment of these 2,804 equity shares was kept in abeyance, pending FIPB approval.
Consequently w.e.f. December 17, 2014, the paid-up equity capital of the Company stands increased to Rs. 8,88,32,540/- from Rs. 8,88,04,500. |
|
|